Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 3
2018 6
2019 9
2020 4
2021 9
2022 9
2023 3
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Seroprevalence of SARS-CoV-2 antibodies in Bangladesh related to novel coronavirus infection.
Bhuiyan TR, Akhtar M, Akter A, Khaton F, Rahman SIA, Ferdous J, Nazneen A, Sumon SA, Banik KC, Bablu AR, Alamgir ASM, Rahman M, Tony SR, Hossain K, Calderwood SB, Charles RC, Ryan ET, LaRocque RC, Harris JB, Rahman M, Chakraborty N, Rahman M, Arifeen SE, Flora MS, Shirin T, Banu S, Qadri F. Bhuiyan TR, et al. IJID Reg. 2022 Mar;2:198-203. doi: 10.1016/j.ijregi.2022.01.013. Epub 2022 Feb 2. IJID Reg. 2022. PMID: 35721426 Free PMC article.
Covishield vaccine induces robust immune responses in Bangladeshi adults.
Bhuiyan TR, Akhtar M, Khaton F, Rahman SIA, Ferdous J, Alamgir ASM, Rahman M, Kawser Z, Hasan I, Calderwood SB, Harris JB, Charles RC, LaRocque RC, Ryan ET, Banu S, Shirin T, Qadri F. Bhuiyan TR, et al. IJID Reg. 2022 Jun;3:211-217. doi: 10.1016/j.ijregi.2022.04.006. Epub 2022 Apr 29. IJID Reg. 2022. PMID: 35720155 Free PMC article.
Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations.
Akhtar M, Islam MR, Khaton F, Soltana UH, Jafrin SA, Rahman SIA, Tauheed I, Ahmed T, Khan II, Akter A, Khan ZH, Islam MT, Khanam F, Biswas PK, Ahmmed F, Ahmed S, Rashid MM, Hossain MZ, Alam AN, Alamgir ASM, Rahman M, Ryan ET, Harris JB, LaRocque RC, Flora MS, Chowdhury F, Khan AI, Banu S, Shirin T, Bhuiyan TR, Qadri F. Akhtar M, et al. Front Immunol. 2023 Dec 20;14:1309997. doi: 10.3389/fimmu.2023.1309997. eCollection 2023. Front Immunol. 2023. PMID: 38173725 Free PMC article.
Correlation of antigen-specific immune response with disease severity among COVID-19 patients in Bangladesh.
Bhuiyan TR, Al Banna H, Kaisar MH, Karmakar PC, Hakim A, Akter A, Ahmed T, Tauheed I, Islam S, Hasnat MA, Sumon MA, Rashed A, Ghosh S, Clemens JD, Banu S, Shirin T, Weiskopf D, Sette A, Chowdhury F, Qadri F. Bhuiyan TR, et al. Front Immunol. 2022 Sep 28;13:929849. doi: 10.3389/fimmu.2022.929849. eCollection 2022. Front Immunol. 2022. PMID: 36248882 Free PMC article.
Scalable production and immunogenicity of a cholera conjugate vaccine.
Jeon S, Kelly M, Yun J, Lee B, Park M, Whang Y, Lee C, Halvorsen YD, Verma S, Charles RC, Harris JB, Calderwood SB, Leung DT, Bhuiyan TR, Qadri F, Kamruzzaman M, Cho S, Vann WF, Xu P, Kováč P, Ganapathy R, Lynch J, Ryan ET. Jeon S, et al. Vaccine. 2021 Nov 16;39(47):6936-6946. doi: 10.1016/j.vaccine.2021.10.005. Epub 2021 Oct 27. Vaccine. 2021. PMID: 34716040 Free PMC article.
Estimating cholera incidence with cross-sectional serology.
Azman AS, Lessler J, Luquero FJ, Bhuiyan TR, Khan AI, Chowdhury F, Kabir A, Gurwith M, Weil AA, Harris JB, Calderwood SB, Ryan ET, Qadri F, Leung DT. Azman AS, et al. Sci Transl Med. 2019 Feb 20;11(480):eaau6242. doi: 10.1126/scitranslmed.aau6242. Sci Transl Med. 2019. PMID: 30787170 Free PMC article.
42 results